CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues:
Product revenue, net	$ 14,638	$ 0	$ 14,638	$ 0
Operating expenses:
Cost of sales	636	0	636	0
Research and development	71,091	68,605	142,328	130,759
Selling, general and administrative	105,448	17,845	186,249	34,027
Total operating expenses	177,175	86,450	329,213	164,786
Loss from operations	(162,537)	(86,450)	(314,575)	(164,786)
Interest income	14,222	3,551	22,556	7,327
Interest expense	(3,656)	(2,901)	(7,493)	(5,237)
Net loss	$ (151,971)	$ (85,800)	$ (299,512)	$ (162,696)
Net loss per common share:
Basic net loss per common share (in dollars per share)	$ (7.10)	$ (4.69)	$ (14.47)	$ (8.91)
Diluted net loss per common share (in dollars per share)	$ (7.10)	$ (4.69)	$ (14.47)	$ (8.91)
Basic weighted average number of common shares outstanding (in shares)	21,402,646	18,310,952	20,702,041	18,249,778
Diluted weighted average number of common shares outstanding (in shares)	21,402,646	18,310,952	20,702,041	18,249,778